; (B) strengthen activities to combat resistance with respect to zoonotic diseases; (C) advance development and use of rapid and innovative capabilities, including diagnostic tests, for identification and characterization of resistant bacteria and fungi; (D) accelerate basic and applied research and development for new antibiotics, antifungals, and other related therapeutics and vaccines; and (E) support international collaboration and capacities for antimicrobial-resistance prevention, detection, and control. ; (D) by redesignating paragraph (4) as paragraph (5); (E) by inserting after paragraph (3) the following: (4) Action plan Not later than October 1, 2025, and every 5 years thereafter, the task force described in paragraph (1) shall develop and submit to the Committee on Health, Education, Labor, and Pensions and the Committee on Appropriations of the Senate and the Committee on Energy and Commerce and the Committee on Appropriations of the House of Representatives a plan regarding Federal programs and activities to combat antimicrobial resistance, including measurable outcomes, as appropriate, informed by— (A) the agenda described in paragraph (3); (B) input provided by the Advisory Council described in subsection (b); and (C) input from other relevant stakeholders provided pursuant to paragraph (2). ; (2) by redesignating subsections (b) through (o) as subsections (c) through (p), respectively